Theratechnologies Inc. (THERF) Analysts See $0.00 EPS

June 20, 2017 - By Nellie Frank

 Theratechnologies Inc. (THERF) Analysts See $0.00 EPS

Analysts expect Theratechnologies Inc. (OTCMKTS:THERF) to report $0.00 EPS on July, 4. The stock increased 2.80% or $0.15 on June 19, reaching $5.59. About shares traded. Theratechnologies Inc. (OTCMKTS:THERF) has 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.

More notable recent Theratechnologies Inc. (OTCMKTS:THERF) news were published by: Marketwired.com which released: “Theratechnologies Inc.: Ibalizumab 24-Week Pivotal Phase III Study Results …” on January 18, 2017, also Marketwired.com with their article: “Theratechnologies Inc.: Short Supply of EGRIFTA® Announced” published on February 14, 2014, Marketwired.com published: “Theratechnologies Regains Rights to EGRIFTA® (tesamorelin for injection) in …” on May 01, 2014. More interesting news about Theratechnologies Inc. (OTCMKTS:THERF) were released by: Seekingalpha.com and their article: “Theratechnologies Has An Unheralded Blockbuster” published on November 18, 2016 as well as Marketwired.com‘s news article titled: “Theratechnologies and TaiMed Biologics Sign Exclusive Marketing and …” with publication date: March 18, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.